Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
24.32
-0.84 (-3.34%)
Nov 6, 2026, 3:23 PM EST - Market open
Collegium Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +146.71% | Nov 6, 2026 |
| Truist Financial No rating | Truist Financial | Buy Reiterates $49 | Buy | Reiterates | $49 | +101.48% | Nov 6, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $43 → $28 | Hold | Reiterates | $43 → $28 | +15.13% | Nov 6, 2026 |
| Barclays | Barclays | Buy Maintains $48 | Buy | Maintains | $48 | +97.37% | Oct 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 | Buy | Reiterates | $50 | +105.59% | Oct 9, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $45 | Buy | Initiates | $45 | +85.03% | Sep 9, 2026 |
| Needham | Needham | Buy Maintains $56 → $46 | Buy | Maintains | $56 → $46 | +89.14% | Aug 6, 2026 |